Literature DB >> 1443732

Intractable cardiac arrest in children given succinylcholine.

H Rosenberg, G A Gronert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1443732     DOI: 10.1097/00000542-199211000-00040

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  15 in total

1.  Cardiac arrest and rhabdomyolysis after succinylcholine in a healthy child.

Authors:  S Kiyama; T Yoshikawa; Y Kobayashi
Journal:  J Anesth       Date:  1995-12       Impact factor: 2.078

2.  Evidence based medicine. Authors' redefinition is better but not perfect.

Authors:  O R Dearlove; J Rogers; A Sharples
Journal:  BMJ       Date:  1996-07-20

Review 3.  The introduction of new drugs into anaesthetic practice: a perspective in pharmaceutical development and regulation.

Authors:  I Gilron
Journal:  Can J Anaesth       Date:  1995-06       Impact factor: 5.063

4.  FDA group urges sux label reduced to "warning".

Authors:  R C Morell
Journal:  J Clin Monit       Date:  1995-03

5.  Succinylcholine.

Authors:  D R Bevan
Journal:  Can J Anaesth       Date:  1994-06       Impact factor: 5.063

6.  Atropine and succinylcholine: beliefs and controversies in paediatric anaesthesia.

Authors:  V F Blanc
Journal:  Can J Anaesth       Date:  1995-01       Impact factor: 5.063

7.  Is it not the time to stop the use of Scoline (suxamethonium chloride) for rapid sequence intubation?

Authors:  Sangeet Narang
Journal:  Sultan Qaboos Univ Med J       Date:  2011-10-25

Review 8.  Adverse effects of neuromuscular blockers and their antagonists.

Authors:  M Naguib; M M Magboul
Journal:  Drug Saf       Date:  1998-02       Impact factor: 5.606

9.  Ventricular fibrillation and rhabdomyolysis after administration of succinylcholine.

Authors:  R L Braam; J K J Deegens; H J G Jessen; A J M Oude Ophuis; B T J Meursing
Journal:  Neth Heart J       Date:  2003-12       Impact factor: 2.380

Review 10.  Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  W J Book; M Abel; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.